BCBS North Dakota Medical Policy Updates – August 2022

Click here to view the Blue Cross Blue Shield BCBS North Dakota Medical Policy Updates »

August 2022 Medical Policy Updates:

• Betibeglogene autotemcel (Zynteglo).html
• Cardiac Ablation Procedures
• Cardiac Applications of Positron Emission Tomography Scanning
• Chelation Therapy for Off-Label Uses
• Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate, or Dermatologic Tumors_id_4cd5892be912fcd5cfeeae9ce4dd29a277df8b6493185bd4af15ee7743fb.html
• Deep Brain Stimulation
• Diagnosis and Treatment of Obstructive Sleep Apnea for Adults
• Diagnosis and Treatment of Obstructive Sleep Apnea in Children
• Diagnosis and Treatment of Obstructive Sleep Apnea in Pediatric Individuals_id_5485e12dadbb094c980c6563bf1f6867de0b730560b4c2d0b4447127a8df.html
• Discectomy
• Edaravone (Radicava)
• Electrical Nerve Stimulation
• Electrical Stimulation Devices for the Treatment of Arthritis
• Excision Repair Cross-Complementing Factor 1 (ERCC1) Analysis for Non-Small Cell Lung Cancer
• ExperimentalInvestigational
• External Counterpulsation (ECP)
• Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions
• Fecal Analysis in the Diagnosis of Intestinal Dysbiosis
• Gender Affirmation Surgery
• Granulocyte Colony-Stimulating Factors
• Hematopoietic Cell Transplant for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
• Hematopoietic Cell Transplantation Blood Cancers.html
• Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
• Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
• Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
• Hematopoietic Cell Transplantation for Hodgkin Lymphoma
• Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas_id_bd68e852b1431b168c5211c2afad082af6fc1a2ae350c888648025ce8545.html
• Hematopoietic Cell Transplantation for Primary Amyloidosis
• Hematopoietic Cell Transplantation for Waldenstrom Macroglobulinemia
• Hematopoietic Stem-Cell Transplantation for Multiple Myeloma and POEMS Syndrome
• Hematopoietic Stem-Cell Transplantation for Non-Hodgkin Lymphomas
• Hyperbaric Oxygen Therapy
• Infliximab
• Infliximab (Medicaid Expansion)_id_94d3297071f50c32403ae7e8befd3b6e5033727fe152e05619360f9d3ee8.html
• Intravitreal Injections.html
• Ofatumumab (Arzerra)_id_689e0969f3923c8ed71bc4d41563f4d884e8d8cf42a19d6c14b65b63c6e8.html
• Olaratumab (Lartruvo)
• Palonosetron (Aloxi)
• Physical Medicine.html
• Physical Therapy (PT)
• Portable External Infusion Pump
• Removal of Benign or Premalignant Skin Lesions
• Risankizumab-rzaa (Skyrizi) IV.html
• Speech Therapy
• Treatment of Benign or Premalignant Skin Conditions_id_e58e103be23957e7e8ba4ef1513b8f42cea898822a3a17e71a7e281cb288.html
• Treatment of Hyperhidrosis
• Wearable Cardioverter-Defibrillator

Click here to view the Blue Cross Blue Shield BCBS North Dakota Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.